SCHEMBL8515709

SCHEMBL8515709

COc1ccc2c(ccn2-c2ccc(OC3CCN(C(=O)O)C(C(C)(C)C)C3)cn2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 1/20 0.39
TFPI2 P48307 1/20 0.37
MAPT P10636 2/20 0.37
FFAR4 Q5NUL3 1/20 0.35
HRH3 Q9Y5N1 4/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CHRNA7 P36544 1/20 0.34
POLB P06746 1/20 0.34
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8535619 0.90 HRH3 (0.35) HRH3ACACBGPR119
SCHEMBL8644871 0.89 CHRNA7 (0.36) MAPTFFAR4HRH3CHRNA7ACACB
SCHEMBL8514705 0.89 IRAK4 (0.42) FFAR4GPR119
SCHEMBL15253110 0.89 GPR119 (0.38) CHRNA7GPR119
SCHEMBL15253268 0.89 MAPT (0.35) MAPTFFAR4CHRNA7ACACBGPR119
SCHEMBL8618219 0.88 HRH3 (0.34) MAPTFFAR4HRH3CHRNA7ACACB
SCHEMBL15253249 0.88 SCN9A (0.38) MAPT
SCHEMBL8586936 0.87 HRH3 (0.42) HRH3ALDH1A1HPGDPOLB
SCHEMBL15253213 0.87 GPR119 (0.36) FFAR4CHRNA7ACACBGPR119
SCHEMBL8611402 0.87 GPR119 (0.33) FFAR4CHRNA7ACACBGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643311-A1 BICYCLIC GPR119 MODULATORS Lupin Limited (IN) 2013-10-02 EP claimed
WO-2012069917-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2012-05-31 WO claimed
US-9000175-B2 Bicyclic GPR119 modulators LUPIN LIMITED (IN) 2015-04-07 US disclosed
EP-2643311-A1 BICYCLIC GPR119 MODULATORS Lupin Limited (IN) 2013-10-02 EP disclosed
US-20130245000-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2013-09-19 US disclosed
WO-2012069917-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2012-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130245000-A1 BICYCLIC GPR119 MODULATORS GPR119, GPR180, GPBAR1 ROCK1 2378/4885TFPI2 2325/4885MAPT 4305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.